drugset / Trial / NCT01935635
A Clinical Trial on HB-Vac Activated-DCs Combined With Peg-IFN or NAs in CHB
Phase 1/2
Completed
400 enrolled
Third Affiliated Hospital, Sun Yat-Sen University
Ruijin Hospital · collabSecond People's Hospital of Yunnan Province · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate whether HB-Vac Activated-DCs Combined With Peg-IFN or NAs has more efficacy than Peg-IFN or NAs alone in the treatment of chronic hepatitis B patients
Timeline
- Start
- 2015-01
- Primary completion
- 2019-12
- Completion
- 2019-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HPDCs-T | Unknown | 200000 cells | Intravenous |
| Subject | HPDCs-T | Unknown | 1e+06 cells | Intravenous |